Breaking News

Fujifilm Irvine Scientific Launches BalanCD HEK293 Viral Feed

Is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.

Author Image

By: Charlie Sternberg

Associate Editor

Fujifilm Irvine Scientific Inc., a leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has launched its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.   Numerous gene therapies have received FDA approval and as more viral ve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters